FibroBiologics Stock Quote FBLG - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.31

Bid

4.12

Ask

6.39

Volume

0.00 Day's Range 0.00

3.90 52 Week Range 55.00

Market Cap

173.739M

Previous Close

5.31

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

192,704

Shares Outstanding

32,719,125

Dividend Yield

PE Ratio

-9.12

Earnings Per Share (EPS)

-0.58

Revenue

Net Profit

-19.06M

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.fibrobiologics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBLG. The last closing price for FibroBiologics was $5.31. Over the last year, FibroBiologics shares have traded in a share price range of $ 3.90 to $ 55.00.

FibroBiologics currently has 32,719,125 shares outstanding. The market capitalization of FibroBiologics is $173.74 million. FibroBiologics has a price to earnings ratio (PE ratio) of -9.12.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.38	7.70791075051	4.93	5.44	4.42	158097	4.91273257	CS
4	-0.94	-15.04	6.25	6.7	3.9	243666	4.74323639	CS
12	-5.6	-51.329055912	10.91	13.59	3.9	192704	7.75996937	CS
26	-24.69	-82.3	30	55	3.9	145375	9.43758769	CS
52	-24.69	-82.3	30	55	3.9	145375	9.43758769	CS
156	-24.69	-82.3	30	55	3.9	145375	9.43758769	CS
260	-24.69	-82.3	30	55	3.9	145375	9.43758769	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHIMShimmick Corporation	$ 3.15 (52.17%)	513.36k
APVOAptevo Therapeutics Inc	$ 0.4905 (46.42%)	4.63M
ADVMAdverum Biotechnologies Inc	$ 11.30 (26.68%)	59.48k
ALSAAlpha Star Acquisition Corporation	$ 12.25 (17.22%)	5
AFARAura FAT Projects Acquisition Corporation	$ 14.60 (16.80%)	17.4k
FIVEFive Below Inc	$ 88.10 (-13.69%)	7.72k
ESPREsperion Therapeutics Inc	$ 2.46 (-9.89%)	35.51k
SILOSilo Pharma Inc	$ 2.16 (-9.62%)	134.02k
MIRAMIRA Pharmaceuticals Inc	$ 0.7401 (-8.63%)	1
LCFYLocafy Ltd	$ 4.98 (-8.62%)	2.67k
APVOAptevo Therapeutics Inc	$ 0.4905 (46.42%)	4.63M
SQQQProShares UltraPro Short QQQ	$ 7.745 (3.82%)	609.53k
NVDANVIDIA Corporation	$ 122.89 (-2.75%)	558.94k
SHIMShimmick Corporation	$ 3.15 (52.17%)	513.36k
MAXNMaxeon Solar Technologies Ltd	$ 0.2439 (-3.37%)	512.77k